A. ÜNAL Et Al. , "Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma," ANNALS OF ONCOLOGY , vol.15, pp.161, 2004
ÜNAL, A. Et Al. 2004. Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma. ANNALS OF ONCOLOGY , vol.15 , 161.
ÜNAL, A., Sari, I., Eser, B., KULA, M., Altuntas, F., & ÇETİN, M., (2004). Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma. ANNALS OF ONCOLOGY , vol.15, 161.
ÜNAL, ALİ Et Al. "Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma," ANNALS OF ONCOLOGY , vol.15, 161, 2004
ÜNAL, ALİ Et Al. "Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma." ANNALS OF ONCOLOGY , vol.15, pp.161, 2004
ÜNAL, A. Et Al. (2004) . "Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma." ANNALS OF ONCOLOGY , vol.15, p.161.
@article{article, author={ALİ ÜNAL Et Al. }, title={Ga-67 uptake: A predictor of active minimaly residual disease and clinical outcome in patients with diffuse large cell lymphoma}, journal={ANNALS OF ONCOLOGY}, year=2004, pages={161} }